Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells (Q38327752)

2 September 2017

title

Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells (English)

1 reference

2 September 2017

main subject

hepatocellular carcinoma

1 reference

10

1 reference

2 September 2017

Ziwen Liu

1

1 reference

2 September 2017

Ruilan Yan

2

1 reference

2 September 2017

Ahmed Al-Salman

3

1 reference

2 September 2017

Yi Shen

4

1 reference

2 September 2017

Yiwen Bu

5

1 reference

2 September 2017

Jun Ma

6

1 reference

2 September 2017

Di-Xian Luo

7

1 reference

2 September 2017

Chenfei Huang

8

1 reference

2 September 2017

Yuyang Jiang

9

1 reference

2 September 2017

Yin-Yuan Mo

11

1 reference

2 September 2017

Mei Chris Huang

12

1 reference

2 September 2017

Yupei Zhao

13

1 reference

2 September 2017

Deliang Cao

14

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 March 2012

1 reference

2 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Biochemical Journal

1 reference

2 September 2017

volume

442

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

273-282

1 reference

Identification and characterization of a novel human aldose reductase-like gene

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Thiol-disulfide exchanges modulate aldo-keto reductase family 1 member B10 activity and sensitivity to inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

The aldo-keto reductase superfamily homepage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Overexpression of aldose reductase in liver cancers may contribute to drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

The aldo-keto reductase superfamily and its role in drug metabolism and detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Aldo-keto reductases and bioactivation/detoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Human aldo-keto reductases 1B1 and 1B10: a comparative study on their enzyme activity toward electrophilic carbonyl compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Reduced 293T cell susceptibility to acrolein due to aldose reductase-like-1 protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Fibrates in the chemical action of daunorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Smoking-induced upregulation of AKR1B10 expression in the airway epithelium of healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

AKR1B10 in usual interstitial pneumonia: expression in squamous metaplasia in association with smoking and lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Regulation of aldo-keto reductase AKR1B10 gene expression: involvement of transcription factor Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Insulin and EGF receptors integrate the Ras and Rap signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

The EGF receptor family: spearheading a merger of signaling and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

How insulin receptor substrate proteins regulate the metabolic capacity of the liver--implications for health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Structure and promoter characterization of aldo-keto reductase family 1 B10 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

EAPII interacts with ETS1 and modulates its transcriptional function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

A new group of conserved coactivators that increase the specificity of AP-1 transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Pivotal role of c-Fos in nitric oxide synthase 2 expression in airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Endotoxin-induced down-regulation of Elk-3 facilitates heme oxygenase-1 induction in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Perinatal hypoxia-/ischemia-induced endothelin-1 mRNA in astrocyte-like and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Sp1 and AP-1 regulate expression of the human gene VIL2 in esophageal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

Lipid rafts and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111322

21 January 2018

Identifiers

DOI

10.1042/BJ20111322

1 reference

2 September 2017

1 reference